CAM
IBB icon

Carret Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Carret Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Sell
2,404
-45
-2% -$7.74K 0.04% 228
2026
Q1 		$414K Hold
2,449
– – 0.04% 223
2025
Q4 		$413K Buy
2,449
+5
+0.2% +$812 0.04% 220
2025
Q3 		$353K Hold
2,444
– – 0.03% 228
2025
Q2 		$309K Sell
2,444
-125
-5% -$15.3K 0.03% 238
2025
Q1 		$329K Sell
2,569
-213
-8% -$28.9K 0.04% 225
2024
Q4 		$368K Sell
2,782
-22
-0.8% -$3.09K 0.04% 213
2024
Q3 		$408K Hold
2,804
– – 0.04% 205
2024
Q2 		$385K Sell
2,804
-9
-0.3% -$1.2K 0.04% 200
2024
Q1 		$386K Sell
2,813
-120
-4% -$16.4K 0.05% 206
2023
Q4 		$398K Sell
2,933
-85
-3% -$10.4K 0.05% 199
2023
Q3 		$369K Buy
3,018
+50
+2% +$6.36K 0.05% 197
2023
Q2 		$377K Sell
2,968
-100
-3% -$13K 0.05% 202
2023
Q1 		$396K Sell
3,068
-310
-9% -$40.6K 0.06% 200
2022
Q4 		$443K Sell
3,378
-95
-3% -$12.3K 0.06% 192
2022
Q3 		$406K Sell
3,473
-360
-9% -$44.7K 0.06% 193
2022
Q2 		$451K Buy
3,833
+5
+0.1% +$594 0.06% 196
2022
Q1 		$499K Sell
3,828
-150
-4% -$19.5K 0.06% 197
2021
Q4 		$607K Sell
3,978
-9
-0.2% -$1.39K 0.07% 188
2021
Q3 		$645K Sell
3,987
-535
-12% -$90K 0.08% 176
2021
Q2 		$740K Sell
4,522
-79
-2% -$12.2K 0.09% 170
2021
Q1 		$693K Hold
4,601
– – 0.09% 164
2020
Q4 		$697K Sell
4,601
-6
-0.1% -$857 0.09% 153
2020
Q3 		$624K Buy
4,607
+477
+12% +$64.7K 0.09% 151
2020
Q2 		$565K Buy
4,130
+145
+4% +$18.5K 0.09% 151
2020
Q1 		$429K Sell
3,985
-225
-5% -$25.9K 0.08% 153
2019
Q4 		$507K Buy
4,210
+732
+21% +$81.7K 0.07% 173
2019
Q3 		$346K Buy
3,478
+632
+22% +$66.2K 0.05% 199
2019
Q2 		$310K Buy
2,846
+250
+10% +$26.6K 0.05% 212
2019
Q1 		$290K Buy
2,596
+65
+3% +$7.13K 0.05% 215
2018
Q4 		$244K Buy
2,531
+700
+38% +$74.3K 0.04% 220
2018
Q3 		$223K Buy
+1,831
New +$216K 0.03% 248

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Carret Asset Management's IBB Position: Q2 2026 in Review

Carret Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q2 2026, selling an estimated $7.74K and leaving 2,404 shares worth $457K. The position accounts for 0.04% of the portfolio, ranked #228.

Carret Asset Management first reported a position in IBB in Q3 2018 and has held it in 32 quarters since. The position peaked at $740K in Q2 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Carret Asset Management held 2,404 shares of iShares Biotechnology ETF worth $457K as of Q2 2026.
  • Carret Asset Management sold 45 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.74K.
  • iShares Biotechnology ETF made up 0.04% of Carret Asset Management's portfolio in Q2 2026, its #228 holding.
  • Carret Asset Management first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 32 quarters since.
  • Carret Asset Management's iShares Biotechnology ETF position peaked at $740K in Q2 2021.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Carret Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.